China's National Health Commission has initiated investigations into suspected medical insurance fraud at several psychiatric hospitals in Hubei province in central China.
China's insurance industry chalked up total premium income of around CNY6.12tn ($882bn), up by 7.4% year on year, driven by the life market, according to data released by the National Financial Regulatory Administration (NFRA).
P&C insurers reported a total premium income of CNY1.76tn ($253bn) in 2025, up by 3.9% year on year, boosted by the health insurance branch, according to data from the National Financial Regulatory Administration (NFRA).
Life insurance companies reported a combined CNY4.36tn ($629bn) in premium income in 2025, up by 8.9% over 2024, due to strong demand for savings.
Seventy-five unlisted P&C insurers have reported a combined net profit of CNY14.63bn ($2.11bn) for the financial year ended 31 December 2025, representing a surge of 180.6% over 2024.
Fifty-seven (57) unlisted life insurers have reported a combined net profit of CNY66.62bn ($9.60bn) for the financial year ended 31 December 2025, representing a surge of 167.7% over 2024, according to the insurers' unaudited 4Q2025 solvency reports.
China's State Council, which is the country's Cabinet, and the Communist Party of China's (CPC) Central Committee have released the first policy statement for 2026, that focuses on agriculture, rural areas, and farmers (known as the 'three rural issues').
China Life Insurance (China Life), the country's biggest life insurer, has announced that it intends to form a partnership that will invest in growth-stage enterprises or strategic emerging industries by acquiring minority equity interests directly.
Hong Kong and Shanghai-listed China Life Insurance Company (China Life) has announced that it intends to enter into an agreement with China Life Qiyuan by 30 September 2026 to form a partnership to establish or acquire project companies engaged in the senior care real estate business, either directly or through its invested funds.
Nasdaq-listed Pomdoctor, an online medical services platform for chronic diseases in China, has announced a strategic initiative to deepen the integration of its platform with China's national and local coordinated medical insurance systems across major cities nationwide.